A team of investigators conducted a multicenter, randomized trial to assess stent dysfunction in covered and uncovered self-expandable metal stents in the setting of malignant gastric outlet obstruction.
Investigators of the longitudinal cohort study evaluated follow-up gastroscopy results from patients who underwent surveillance 3 years after receiving a diagnosis of autoimmune or multifocal atrophic gastritis.
Data from the phase-3 investigation of avelumab vs chemotherapy as maintenance therapies for the treatment of gastric or gastroesophageal junction cancer were published in the Journal of Clinical Oncology.
Investigators sought to identify the “optimal parameters” for gastric electrical stimulation and determine whether they are associated with improved symptoms and long-term clinical outcomes in patients with gastroparesis.
Investigators of the retrospective cohort study evaluated adherence to guideline-supported eradication testing for Helicobacter pylori infection.
Investigators evaluated the discovery rate of eosinophilic gastritis and eosinophilic duodenitis in patients with chronic non-specific gastrointestinal symptoms who enrolled in the phase-2 ENIGMA trial.
Investigators compared the efficacy of linked color imaging and white light imaging in detecting neoplastic lesions in the upper gastrointestinal tract.
Investigators evaluated the impact of insurance status on gastric cancer survival outcomes in patients treated at a safety-net hospital.
Investigators sought to evaluate the role of breast milk immunoglobulin A (IgA) in norovirus (NV) infection and diarrhea in infants to determine whether breast milk IgA has a preventive effect against NV infection and subsequent diarrhea.
The supplemental Biologics License Application includes data from the open-label, randomized phase 2 DESTINY-Gatric01 trial.
